Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Matthew Beal

Adult Reconstructive Orthopaedic Surgery Columbus, OH Medical Doctor

NPI 1346406956 CMS profile 1028254

543 Taylor Ave, Columbus, OH 43203

Open in the dashboard

General payments

$319,469

144 records reported · program years 2019–2025

Research payments

$2,252

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Matthew Beal of Columbus, OH is reported in the CMS Open Payments database as having received $319,469 across 144 general payments and $2,252 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,046 6
2024 General $8,682 16
2023 General $24,507 24
2022 General $64,903 25
2021 General $70,529 27
2021 Research $2,252 1
2020 General $68,535 23
2019 General $81,267 23

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Matthew Beal
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to Matthew Beal were reported at $1,046. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year Matthew Beal Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $81,267 $1,416 $292–$9,336 $163
2020 $68,535 $647 $141–$6,474 $114
2021 $70,529 $1,073 $211–$6,497 $132
2022 $64,903 $1,217 $236–$6,299 $149
2023 $24,507 $1,082 $246–$6,818 $160
2024 $8,682 $1,575 $323–$8,944 $164
2025 $1,046 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medacta USA, Inc. $317,395 113 payments
  2. Solventum Corporation $600 1 payment
  3. Stryker Corporation $486 4 payments
  4. Think Surgical, Inc. $326 4 payments
  5. Zimmer Biomet Holdings, Inc. $147 2 payments
  6. Smith+Nephew, Inc. $114 1 payment
  7. Onkos Surgical, Inc. $100 2 payments
  8. Ferring Pharmaceuticals Inc. $97 7 payments
  9. DePuy Synthes Sales Inc. $46 2 payments
  10. Dynasplint Systems Inc. $28 1 payment
  11. Other $130 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $206,861 16 payments
  2. Consulting Fee $86,175 13 payments
  3. Travel and Lodging $11,830 35 payments
  4. Honoraria $9,600 1 payment
  5. Food and Beverage $5,003 79 payments
Products named General payments · program years 2019–2025
  1. MASTERLOC $206,861 16 payments
  2. GMK SPHERE $55,942 39 payments
  3. AMISTEM $9,957 22 payments
  4. GMK Sphere Revision System $7,833 8 payments
  5. MYKNEE $7,651 4 payments
  6. MOTO Partial Knee System $686 4 payments
  7. PREVENA $600 1 payment
  8. V.A.C. VERAFLO $600 1 payment
  9. ABTHERA $600 1 payment
  10. V.A.C. VERAFLO CLEANSE CHOICE $600 1 payment
  11. Other $2,947 55 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medacta USA, Inc. $2,252 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

19

Median for Orthopedic Surgery: 203

Drug cost

$22

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Amoxicillin Generic 19 $22

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 28 billing codes

Paid by Medicare

$118,833

Of which drugs: $742

Medicare patients

313

Average age 72

Services billed

711

186 women, 127 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 32%
Diabetes 27%
Ischemic heart disease 23%
Cancer 19%
Osteoporosis 17%
Atrial fibrillation 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 22 108 $74

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

145 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adult Reconstructive Orthopaedic Surgery in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record